Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study. J Clin Psychopharmacol. 2002;22(3):285–293.

Raphael KC, Matuja SS, Shen NT, Liwa AC, Jaka H. Hepatic encephalopathy; prevalence, precipitating factors and challenges of management in a resource-limited setting. J Gastrointest Digest Syst. 2016;6(3):441. doi: 10.4172/2161-069X.1000441

Rosner S, Soyka M, Hajak G, Wehrle R, Englbrecht C. Eszopiclone for insomnia. Cochrane Database System Rev. 2013;8(CD010703). doi: 10.1002/14651858.CD010703

Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508–513. doi: 10.1001/archinternmed.2007.106

Sabia S, Elbaz A, Britton A, Bell S, Dugravot A, Shipley M, Kivimaki M, Singh-Manoux A. Alcohol consumption and cognitive decline in early old age. Neurology. 2014;82(4):332–339. doi: 10.1212/WNL.0000000000000063. Epub 2014 Jan 15.

Sacks O, Shulman M. Steroid dementia: An overlooked diagnosis? Neurology. 2005;64:707–709.

Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J; QalyDays Study Group. Contribution of alcohol use disorders to the burden of dementia in France 2008–13: a nationwide retrospective cohort study. Lancet Public Health. 2018;3(3):e124–132. doi: 10.1016/S2468-2667(18)30022-7. Epub 2018 Feb 21.

Topiwala A, Allan CL, Valkanova V, et al. Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study. BMJ. 2017;357:j2353. doi: 10.1136/bmj.j2353

Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715–735. doi: 10.1002/hep.27210. Epub 2014 Jul 8.

Weigand AJ, Bondi MW, Thomas KR, et al. Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults. Neurology. 2020;95(16) e2295–e2304. doi: 10.1212/WNL.0000000000010643

Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology. 2004;39(3):739–745. doi: 10.1002/hep.20095

Wright JD, Cogan JC, Huang Y, et al. Association of new perioperative benzodiazepine use with persistent benzodiazepine use. JAMA Netw Open. 2021;4(6):e2112478. doi: 10.1001/jamanetworkopen.2021.12478

Wu CS, Ting TT, Wang SC, Chang IS, Lin KM. Effect of benzodiazepine discontinuation on dementia risk. Am J Geriatr Psychiatry. 2011;19(2):151–159. doi: 10.1097/JGP.Ob013e3181e049ca

Zhang R, Shen L, Miles T, et al. Association of low to moderate alcohol drinking with cognitive functions from middle to older age among US adults. JAMA Netw Open. 2020;3(6):e207922. doi: 10.1001/jamanetworkopen.2020.7922

Bamia C, Trichopoulou A, Trichopoulos D. Age at retirement and mortality in a general population sample: the Greek EPIC study. Am J Epidemiol. 2008;167(5):561–569. doi: 10.1093/aje/kwm337. Epub 2007 Dec 3.

Bialystok E. Bilingualism: pathway to cognitive reserve. Trends Cogn Sci. 2021;25(5):355–364. doi: 10.1016/j.tics.2021.02.003. Epub 2021 Mar 23.

Biddle KD, Jacobs HIL, d’Oleire Uquillas F, et al. Associations of widowhood and ?-amyloid with cognitive decline in cognitively unimpaired older adults. JAMA Netw Open. 2020;3(2):e200121. doi: 10.1001/jamanetworkopen.2020.0121

Brenowitz WD, Besser LM, Kukull WA, Keene CD, Glymour MM, Yaffe K. Clinician-judged hearing impairment and associations with neuropathologic burden. Neurology. 2020;95(12):e1640–e1649; doi: 10.1212/WNL.0000000000010575

Bubbico G, Chiacchiaretta P, Parenti M, et al. Effects of second language learning on the plastic aging brain: functional connectivity, cognitive decline, and reorganization. Front Neurosci. 2019;13:423. doi: 10.3389/fnins.2019.00423. eCollection 2019.

Deal JA, Goman AM, Albert MS, et al. Hearing treatment for reducing cognitive decline: design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial. Alzheimer Dement. 2018;4:499–507. doi: 10.1016/j.trci.2018.08.007 248 For Further Reading